Abiopharma

News list

(99% Neutral) Decibel Therapeutics, Inc. (DBTX) Announces Clinical Development Update

Full text

News bot Oct. 3, 2025, 9:16 a.m.
📋 Decibel Therapeutics, Inc. (DBTX) - Clinical Trial Update

Filing Date: 2022-10-17

Accepted: 2022-10-17 07:39:35

Event Type: Clinical Trial Update
Event Details:
Decibel Therapeutics Inc (was acquired Regeneron Pharmaceuticals Inc (REGN)) (DBTX) Announces Clinical Trial Update Decibel Therapeutics Inc (was acquired Regeneron Pharmaceuticals Inc (REGN)) (DBTX) provided an update on its clinical development programs. Clinical Development Highlights:
Drug Program: Specified
💼 Business Developments:
- Partnership: Not available
- Acquisition: Not available
- Licensing: Not available
- Regulatory Approval
- Executive Changes: Not available
Structured Data:
- Company Name: Decibel Therapeutics Inc (was acquired Regeneron Pharmaceuticals Inc (REGN))
- CIK: 0001656536
- Ticker Symbol: DBTX
- Period End Date: 2022-10-17
- Document Type: 8-K